Temporal Image Comparison (Serial Imaging) in Assessing Pigmented Lesions - 07/09/17
, Elizabeth D. Drugge, PhD, MPH bRiassunto |
The large-scale deployment of low-cost, noninvasive mechanisms of early detection are needed to reduce the melanoma burden. A serial 2-step system could power mass screening efforts serving the uninsured and underinsured as well as the rural and remote US counties where melanoma mortality is doubled for lack of access to dermatologists. Furthermore, serial melanoma screening strategies, serial total body photography and serial digital dermatoscopy imaging may be performed as a telehealth service, and thus would be available in any location that can support activity compliant with the Health Insurance Portability and Accountability Act and has appropriate bandwidth.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Melanoma, Screening, Serial imaging, Two-step method of digital follow-up, Total body photography, Temporal image comparison
Mappa
| Disclosure: R.J. Drugge is the inventor of the Melanoscan system, US Patent #7,359,748 and owner of Melanoscan, LLC. |
Vol 35 - N° 4
P. 447-451 - ottobre 2017 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
